Redmile as of Dec. 31, 2014
Portfolio Holdings for Redmile
Redmile holds 54 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 6.2 | $57M | 6.9M | 8.32 | |
| Array BioPharma | 6.1 | $56M | 12M | 4.73 | |
| Valeant Pharmaceuticals Int | 5.3 | $48M | 339k | 143.11 | |
| Chimerix (CMRX) | 5.1 | $47M | 1.2M | 40.26 | |
| Rite Aid Corporation | 4.9 | $45M | 6.0M | 7.52 | |
| Clovis Oncology | 4.4 | $40M | 722k | 56.00 | |
| Celgene Corporation | 4.2 | $38M | 342k | 111.86 | |
| Receptos | 4.2 | $38M | 313k | 122.51 | |
| Avalanche Biotechnologies In | 4.1 | $38M | 699k | 54.00 | |
| Gilead Sciences (GILD) | 3.8 | $35M | 369k | 94.26 | |
| Seattle Genetics | 3.4 | $32M | 984k | 32.13 | |
| Trivascular Technologies | 2.4 | $22M | 1.8M | 12.57 | |
| Zs Pharma | 2.4 | $22M | 525k | 41.57 | |
| Healthways | 2.3 | $21M | 1.1M | 19.88 | |
| D Fluidigm Corp Del (LAB) | 2.2 | $21M | 610k | 33.73 | |
| AstraZeneca (AZN) | 2.0 | $18M | 258k | 70.38 | |
| McKesson Corporation (MCK) | 2.0 | $18M | 88k | 207.58 | |
| Puma Biotechnology (PBYI) | 1.9 | $18M | 94k | 189.27 | |
| Nanostring Technologies (NSTGQ) | 1.9 | $18M | 1.3M | 13.93 | |
| Intra Cellular Therapies (ITCI) | 1.9 | $18M | 991k | 17.65 | |
| Bellicum Pharma | 1.9 | $17M | 861k | 20.06 | |
| NuVasive | 1.8 | $17M | 359k | 47.16 | |
| Health Net | 1.8 | $17M | 309k | 53.53 | |
| Insmed (INSM) | 1.7 | $16M | 1.0M | 15.47 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.7 | $16M | 751k | 20.94 | |
| Model N (MODN) | 1.7 | $16M | 1.5M | 10.62 | |
| Universal Health Services (UHS) | 1.6 | $15M | 135k | 111.26 | |
| Civitas Solutions | 1.6 | $15M | 880k | 17.03 | |
| Biogen Idec (BIIB) | 1.6 | $15M | 43k | 339.46 | |
| Oxford Immunotec Global | 1.6 | $15M | 1.1M | 13.62 | |
| Castlight Health | 1.6 | $15M | 1.2M | 11.70 | |
| Globus Med Inc cl a (GMED) | 1.6 | $15M | 612k | 23.77 | |
| Accuray Incorporated (ARAY) | 1.3 | $12M | 1.5M | 7.55 | |
| Achaogen | 1.0 | $9.6M | 734k | 13.05 | |
| Bluebird Bio (BLUE) | 1.0 | $9.4M | 102k | 91.72 | |
| Nevro (NVRO) | 1.0 | $9.1M | 234k | 38.67 | |
| Connecture | 0.9 | $8.5M | 943k | 9.01 | |
| Atara Biotherapeutics (ATRA) | 0.8 | $7.1M | 264k | 26.75 | |
| eHealth (EHTH) | 0.7 | $6.6M | 265k | 24.92 | |
| Flexion Therapeutics | 0.7 | $6.4M | 315k | 20.19 | |
| Tokai Pharmaceuticals | 0.3 | $3.2M | 215k | 14.74 | |
| Eleven Biotherapeutics | 0.3 | $2.9M | 240k | 11.88 | |
| Pacific Biosciences of California (PACB) | 0.2 | $1.9M | 238k | 7.84 | |
| Array Biopharma Inc note 3.000% 6/0 | 0.2 | $1.9M | 2.0M | 0.93 | |
| Loxo Oncology | 0.2 | $1.6M | 138k | 11.75 | |
| Forward Pharma A/s | 0.1 | $526k | 25k | 20.84 | |
| Celldex Therapeutics | 0.1 | $476k | 26k | 18.24 | |
| Market Vectors Etf Tr pharmaceutical | 0.1 | $418k | 6.5k | 64.31 | |
| WellCare Health Plans | 0.0 | $401k | 4.9k | 82.05 | |
| PowerShares QQQ Trust, Series 1 | 0.0 | $355k | 3.4k | 103.38 | |
| iShares NASDAQ Biotechnology Index (IBB) | 0.0 | $303k | 1.0k | 303.00 | |
| Alexion Pharmaceuticals | 0.0 | $257k | 1.4k | 184.89 | |
| iShares Dow Jones US Health Care (IHF) | 0.0 | $296k | 2.5k | 118.40 | |
| Sunesis Pharmaceuticals | 0.0 | $64k | 25k | 2.56 |
